The authors conclude that PCNU, at the dose and schedule administered, does not have useful activity in patients with non-small cell lung cancer.
|Original language||English (US)|
|Number of pages||1|
|Journal||Cancer Treatment Reports|
|State||Published - 1983|
ASJC Scopus subject areas
- Cancer Research